Algernon Pharmaceuticals (OTC:AGNPF) – A landmark study in stroke
biopharmaceutical company Algernon Pharmaceuticals Inc AGNPF recently announced plan for a Phase 1 clinical trial of DMT in human stroke just got approval from the
biopharmaceutical company Algernon Pharmaceuticals Inc AGNPF recently announced plan for a Phase 1 clinical trial of DMT in human stroke just got approval from the
NEW YORK, Sept. 12, 2022 (GLOBE NEWSWIRE) — Moore Kuehn, PLLC, a Wall Street-based securities law firm, is investigating whether certain officers and directors of
NEW YORK, Sept. 11, 2022 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, PC, a nationally recognized shareholder rights law firm, is investigating potential claims against
SAN DIEGO, Sept. 09, 2022 (GLOBE NEWSWIRE) — Shareholder Rights Law Firm Johnson Fistel, LLP (www.JohnsonFistula.com) examines whether Eiger BioPharmaceuticals, Inc. OWN, one of its
SAN DIEGO, Sept. 09, 2022 (GLOBE NEWSWIRE) — Shareholder Rights Law Firm Johnson Fistel, LLP (www.JohnsonFistula.com) examines whether Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR), one of
LOS ANGELES, Sept. 9, 2022 (GLOBE NEWSWIRE) — Glancy Prongay & Murray LLP (“GPM”) reminds investors of what’s to come October 17, 2022 Deadline for
BENSALEM, Pa., Sept. 08, 2022 (GLOBE NEWSWIRE) — The law firm of Howard G. Smith is reminding investors that class action lawsuits have been filed
[ad_1] WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) between May 7,
[ad_1] WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) between May 7,
[ad_1] New York, New York–(Newsfile Corp. – May 13, 2022) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the
[ad_1] WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) between May 7,
[ad_1] WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) between May 7, 2021
biopharmaceutical company Algernon Pharmaceuticals Inc AGNPF recently announced plan for a Phase 1 clinical trial of DMT in human stroke just got approval from the
NEW YORK, Sept. 12, 2022 (GLOBE NEWSWIRE) — Moore Kuehn, PLLC, a Wall Street-based securities law firm, is investigating whether certain officers and directors of
NEW YORK, Sept. 11, 2022 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, PC, a nationally recognized shareholder rights law firm, is investigating potential claims against
SAN DIEGO, Sept. 09, 2022 (GLOBE NEWSWIRE) — Shareholder Rights Law Firm Johnson Fistel, LLP (www.JohnsonFistula.com) examines whether Eiger BioPharmaceuticals, Inc. OWN, one of its
SAN DIEGO, Sept. 09, 2022 (GLOBE NEWSWIRE) — Shareholder Rights Law Firm Johnson Fistel, LLP (www.JohnsonFistula.com) examines whether Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR), one of
LOS ANGELES, Sept. 9, 2022 (GLOBE NEWSWIRE) — Glancy Prongay & Murray LLP (“GPM”) reminds investors of what’s to come October 17, 2022 Deadline for
BENSALEM, Pa., Sept. 08, 2022 (GLOBE NEWSWIRE) — The law firm of Howard G. Smith is reminding investors that class action lawsuits have been filed
[ad_1] WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) between May 7,
[ad_1] WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) between May 7,
[ad_1] New York, New York–(Newsfile Corp. – May 13, 2022) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the
[ad_1] WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) between May 7,
[ad_1] WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) between May 7, 2021